Genmab :

* Says Morphosys apparently has filed a complaintat us district court of Delaware against Genmab and partnerJanssen Biotech, inc. for patent infringement relating toDarzalex (daratumumab) in United States

* Says Janssen will in consultation with Genmab determineappropriate action in response to complaint.Source text for Eikon: Further company coverage: (Copenhagen newsroom)



http://feeds.reuters.com/~r/reuters/...aI/story01.htm